Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: CHU Dual-Energy Ablation in Ventricular Arrhythmia [NA]

View source ↗

Summary

The trial update indicates that the CHU Dual-Energy Ablation device is currently enrolling by invitation for patients with premature ventricular contractions an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHU Dual-Energy Ablation

Snippet

Sponsor: Shanghai MicroPort EP MedTech Co., Ltd. | Conditions: Premature Ventricular Contractions, Ventricular Tachycardia | NA | Status: ENROLLING_BY_INVITATION